With over three years of experience in the medical communications business, Catarina holds a BSc. in Biomedical Sciences and a MSc. in Neurosciences. Apart from writing, she has been involved in patient-oriented translational and clinical research.
The World Health Organization (WHO) is launching an international clinical trial to study the use of lupus treatments hydroxychloroquine and chloroquine as potential therapies for pneumonia caused by the ... Read more
Adding Benlysta (belimumab) to standard therapy increased the percentage of people with active lupus nephritis who experienced improved renal function in a Phase 3 trial. The BLISS-LN study (NCT01639339) ... Read more
Treatment with an investigational antibody therapy known as BIIB059 was well-tolerated and decreased disease activity in people with cutaneous lupus erythematosus (CLE) — lupus affecting the skin — with ... Read more
High blood pressure and a skin condition characterized by a netlike pattern of reddish-blue skin discoloration — livedo reticularis — may be risk factors for peripheral nervous system manifestations ... Read more
Systemic lupus erythematosus (SLE) patients treated Benlysta (belimumab) together with standard of care showed significantly lesser evidence of long-term organ damage than those given standard of care alone, a review ... Read more
Lupus nephritis patients with reduced kidney function and high levels of “good” cholesterol are at a greater risk of end-stage renal disease, a new study suggests. On the other hand, ... Read more
Pin It on Pinterest